ORTHOPEDIATRICS CORP
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M |
| Gross profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M |
| Operating income | -$39.2M | -$35.0M | -$26.8M | -$25.4M | -$18.0M |
| Operating expenses | $211.9M | $183.6M | $138.0M | $116.1M | $91.4M |
| Cost of revenue | $63.7M | $56.1M | $37.5M | $31.6M | $24.6M |
| Cash from operations | -$4.9M | -$27.0M | -$27.0M | -$21.8M | -$13.1M |
| Capital expenditure | $11.1M | $14.3M | $16.9M | $10.0M | $8.1M |
| Free cash flow | -$16.0M | -$41.3M | -$43.9M | -$31.8M | -$21.2M |
| Impairments | $1.9M | $0 | $0 | $0 | $0 |
| Total assets | $508.6M | $473.2M | $438.7M | $427.7M | $304.3M |
| Total liabilities | $162.0M | $118.6M | $61.7M | $49.1M | $78.9M |
Shares outstanding 25.7M · Free float 73.0%
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.